2018
DOI: 10.1128/aac.01158-18
|View full text |Cite
|
Sign up to set email alerts
|

Adjunctive Clavulanic Acid Abolishes the Cefazolin Inoculum Effect in an Experimental Rat Model of Methicillin-Sensitive Staphylococcus aureus Endocarditis

Abstract: We tested the ability of clavulanic acid to restore the efficacy of cefazolin against TX0117, which exhibits the cefazolin inoculum effect (CzIE). In the rat infective endocarditis model, the coadministration of cefazolin plus clavulanic acid resulted in a significant reduction of bacterial counts (7.1 ± 0.5 log CFU/g) compared to that with cefazolin alone (2 ± 0.6 log CFU/g; < 0.0001). The addition of a β-lactamase inhibitor may be a viable strategy for overcoming the CzIE.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
10
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 9 publications
(10 citation statements)
references
References 18 publications
(26 reference statements)
0
10
0
Order By: Relevance
“…Interestingly, these investigators found that CzIE and non-CzIE MSSA infections have overall similar outcomes. In addition, studies in rat endocarditis models demonstrate that the use of cefazolin in a CzIE MSSA infection is associated with a more severe disease course which may be ameliorated by the addition of a ␤-lactamase inhibitor with the 1GC (26,32). Such discrepancies could in part be related to differences in populations studied (adults with comorbidities versus otherwise healthy children), as well as measures of treatment success/failure.…”
Section: Discussionmentioning
confidence: 99%
“…Interestingly, these investigators found that CzIE and non-CzIE MSSA infections have overall similar outcomes. In addition, studies in rat endocarditis models demonstrate that the use of cefazolin in a CzIE MSSA infection is associated with a more severe disease course which may be ameliorated by the addition of a ␤-lactamase inhibitor with the 1GC (26,32). Such discrepancies could in part be related to differences in populations studied (adults with comorbidities versus otherwise healthy children), as well as measures of treatment success/failure.…”
Section: Discussionmentioning
confidence: 99%
“…This study is important because it brings ease of application and updates to the IE rat models. Various models of experimental IE have been described to date (5)(6)(7)(8)(9)(10)(11)(12). This study has two important differences from the predefined IE animal models.…”
Section: Discussionmentioning
confidence: 99%
“…The pathophysiology of IE includes endocardial damage, hypercoagulability, and bacteremia. The experimental IE models described to date are based on this pathophysiology (5)(6)(7)(8)(9)(10)(11)(12). Animal models are widely used to investigate new diagnostic methods in IE and to evaluate the efficacy of various antimicrobial agents.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Further, on balancing adverse events vs efficacy metrics, CFZ is generally regarded as a safer option, due to its decreased renal toxicity risk as compared to the antistaphylococcal penicillins (16, 27). However, there remains concern about CFZ efficacy in “high-inoculum” S. aureus infections (e.g., endocarditis) due to the potential for the undetected presence and induction of genes for Types A or C cephalosporinases that hydrolyze CFZ (39, 40). In our current study, CFZ appeared to be unaffected by the high inoculum within SEVs, at least for the NaHCO 3 -responsive strains, 11-11 and MW2, with excellent CFZ bactericidal activity obtained despite starting inocula ≥ 1×10 8 CFU/g.…”
Section: Discussionmentioning
confidence: 99%